Company Monitoring Page for JNJ

latest headlines for company on cafepharma

Johnson & Johnson's COVID-19 Vaccine Inventory Is Lighter Than Expected
Motley Fool
Wed, 02/17/21 - 11:27 pm
Tags:
JNJ, vaccines, COVID-19
Janssen's COVID vaccine application submitted to EMA
RAPS.org
Tue, 02/16/21 - 11:38 pm
Tags:
JNJ, Janssen, EMA, Europe, vaccines, COVID-19
1 Green Flag and 1 Red Flag for Johnson & Johnson's Vaccine Candidate
Motley Fool
Sat, 02/13/21 - 11:07 pm
Tags:
JNJ, Janssen, vaccines, COVID-19
Janssen Shows 35% Drop in Mortality with Prostate Cancer Drug
BioSpace
Wed, 02/10/21 - 12:01 am
Tags:
Janssen, JNJ, Erleada, prostate cancer, clinical trials
Johnson & Johnson CEO: Our Covid-19 Vaccine Will Keep You From Getting ‘Very, Very Sick’
Forbes
Tue, 02/9/21 - 11:59 pm
Tags:
JNJ, Alex Gorsky, Pharma CEOs, COVID-19, vaccines
Johnson & Johnson's Vaccine Is Less Effective Than Rivals. Here's Why It Could Still Win Big
Motley Fool
Sat, 02/6/21 - 11:20 pm
Tags:
JNJ, Moderna Therapeutics, Pfizer, vaccines, COVID-19
FDA arranges Feb. 26 AdComm to discuss J&J COVID-19 vaccine EUA
Fierce Biotech
Fri, 02/5/21 - 10:49 am
Tags:
FDA, JNJ, advisory panels, vaccines, COVID-19, Emergency Use Authorization
J&J asks FDA for emergency clearance of coronavirus vaccine
BioPharma Dive
Thu, 02/4/21 - 08:16 pm
Tags:
JNJ, vaccines, COVID-19, FDA, Emergency Use Authorization
Novavax and Johnson & Johnson Seek Regulatory Approval for COVID-19 Vaccines After Posting Promising Efficacy Data
Xtalks
Wed, 02/3/21 - 10:48 am
Tags:
JNJ, Novavax, COVID-19, vaccines, FDA
JNJ's amivantamab puts more data behind the hype
EP Vantage
Tue, 02/2/21 - 11:11 pm
Tags:
JNJ, amivantamab, exon 20-insertion NSCLC
Janssen flags accelerated approval milestone in Europe for CAR-T therapy
Biopharma Reporter
Mon, 02/1/21 - 11:04 pm
Tags:
JNJ, Janssen, CAR-T, EMA, Europe, cilta-cel
While Pfizer and Moderna hold the lead, new data from J&J, Novavax show there's 'room for everyone' in the market: analysts
Fierce Pharma
Mon, 02/1/21 - 11:01 am
Tags:
Novavax, JNJ, Moderna Therapeutics, Pfizer, BioNTech, vaccines, COVID-19
J&J single shot sees 66% efficacy in moderate COVID-19, 85% in severe cases; shares fall
Fierce Biotech
Fri, 01/29/21 - 10:14 am
Tags:
JNJ, vaccines, COVID-19, B.1.1.7 variant, B.1.351 variant
J&J pushes new amivantamab data for NSCLC subset, trying to bolster case for quick FDA approval
Endpoints
Thu, 01/28/21 - 11:16 pm
Tags:
JNJ, amivantamab, non-small cell lung cancer
Verana strikes research collaboration with Janssen on ophthalmology and urology
MedCity News
Wed, 01/27/21 - 08:02 pm
Tags:
Verana Health, JNJ, Janssen, data analytics, diabetic retinopathy, diabetic macular edema
Johnson & Johnson Rises on Q4 Beats, Coronavirus Vaccine Hopes
Motley Fool
Tue, 01/26/21 - 11:36 pm
Tags:
JNJ, earnings
GSK, Novartis, J&J and Pfizer lead pharma at making their meds accessible: report
Fierce Pharma
Tue, 01/26/21 - 11:30 pm
Tags:
GSK, Novartis, JNJ, Pfizer, accessibility
Johnson & Johnson's closely watched single-shot COVID-19 vaccine readout 'next week' as CFO sees 'robust data'
Fierce Biotech
Tue, 01/26/21 - 11:18 am
Tags:
JNJ, vaccines, COVID-19, clinical trials
COVID-19 Vaccine Leaders Turn Attention to Kids, But Results Not Expected Until 2022
BioSpace
Mon, 01/25/21 - 11:58 pm
Tags:
COVID-19, vaccines, clinical trials, pediatric, Pfizer, Moderna Therapeutics, AstraZeneca, JNJ
AZ says Calquence is a safer drug than Imbruvica
Pharmaforum
Mon, 01/25/21 - 11:02 am
Tags:
AstraZeneca, Calquence, Imbruvica, JNJ, AbbVie, CLL

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.